Dejan Muftic
Commercial Obesity Portfolio Lead at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Dejan Muftic’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Commercial Obesity Portfolio Lead at Novo Nordisk in May 2023 - Present
Senior Global Project Manager at Novo Nordisk in January 2018 - May 2023
Global Product Manager at Novo Nordisk in August 2016 - January 2018
Stockholm School of Economics, Master of Science (MS), November 2026
National University of Singapore
Leiden University
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo NordiskGlobal Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Dejan Muftic email address?
Email Dejan Muftic at [email protected] and [email protected]. This email is the most updated Dejan Muftic's email found in 2026.
How to contact Dejan Muftic?
To contact Dejan Muftic send an email to [email protected] or [email protected]. (updated on April 16, 2026)
What company does Dejan Muftic work for?
Dejan Muftic works for Novo Nordisk.
What is Dejan Muftic's role at Novo Nordisk?
Dejan Muftic is Commercial Obesity Portfolio Lead
What industry does Dejan Muftic work in?
Dejan Muftic works in the Pharmaceuticals industry.